extended-release (ER)
Jump to navigation
Jump to search
Introduction
denoting an oral medication that release slowly over an extended perior of time, similar to sustained action (SA), in contrast to immediate-release.
Notes
- some generics are not equivalent to the brand name counterparts in terms of extended release of active ingredient[1][2][3]
References
- ↑ Jump up to: 1.0 1.1 Thomas K An Increase in Scrutiny for Generics New York Times, Oct 31, 2012 http://www.nytimes.com/2012/11/01/business/fda-increases-scrutiny-of-some-generic-drugs.html
- ↑ Jump up to: 2.0 2.1 FDA Update: October 3, 2012 Budeprion XL 300 mg Not Therapeutically Equivalent to Wellbutrin XL 300 mg http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm322161.htm
- ↑ Jump up to: 3.0 3.1 Orciari Herman A FDA Planning Study of Generic Metoprolol Over Safety, Efficacy Concerns. NEJM Journal Watch. May 9, 2014 Massachusetts Medical Society (subscription needed) http://www.jwatch.org